Clinical Trial Update: Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 trial evaluating autologous tumor-infiltrating lymphocyte therapy for advanced solid tumors is currently recruiting, sponsored by Grit Bi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Autologous tumor-infiltrating lymphocyte therapy (tumor-infiltrating lymphocytes)

Snippet

Sponsor: Grit Biotechnology | Conditions: Solid Tumor, Adult | EARLY_Phase 1 | Status: RECRUITING